Statins
Findings in statins provide new insights
Published in Cardiovascular Week, December 5th, 2005
Study 1: A recent report on the achievement of English National Service Framework lipid-lowering goals refers to pooled data from recent comparative treatment trials of statins at starting doses.
According to the report from England, "Despite the importance of reducing cardiovascular disease (CVD) risk, detailed in guidelines in many countries, repeated surveys show poor physician performance in attaining guideline lipid targets, which is associated with reluctance by physicians to uptitrate statins from starting doses."
F.D. Hobbs and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2005-12-05)
More Articles from Cardiovascular Week
- Angiology
Perivascular adipose tissue controls vascular function in internal thoracic artery - Cardiovascular Disease
G allele in adiponectin gene at SNP 276 may indicate higher CV disease risk - Cardiovascular Disease
Hemodialysis-unresponsive BP patients are more likely to have vascular disease - Cardiovascular Research
Aortic valve calcification is associated with age, HT, and bone mineral density - Kawasaki Disease
Researchers zero in on the possible cause of Kawasaki disease - Acute Peripheral Arterial Occlusion
European Medicines Agency grants orphan drug designation for alfimeprase - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
